Ken Griffin's position in BioCardia - Warrants (26/07/2022) is currently worth $919. That's 0.00% of their equity portfolio (5016th largest holding). Ken Griffin started to build up the position in BioCardia - Warrants (26/07/2022) in Q4 2022 and continued to invest until Q3 2023. Since then they sold 797 shares. The investor's estimated purchase price is $31.5 Thousand, resulting in a loss of 97%.